Clinical & Diagnostic
Bayer AG Partners with Thermo Fisher for Breakthrough in Cancer Treatment Diagnostics
Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapie...
March 20, 2024 | News
AstraZeneca Acquires Fusion Pharmaceuticals in a $2 Billion Upfront Deal
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-gene...
March 19, 2024 | News
Asieris Announces Breakthrough Non-Surgical Treatment for Cervical High-Grade Squamous Intraepithelial Lesion
Asieris Pharmaceuticals (Stock Code: 688176.SH), a trailblazer in the global biopharmaceutical industry with a focus on genitourinary tumors and related di...
March 19, 2024 | News
KeChow Pharma's Tunlametinib Receives Historic Approval in China for Advanced Melanoma Treatment
KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule therapeutics for cancer, t...
March 19, 2024 | News
Revvity Launches Revolutionary Newborn Sequencing Workflow to Advance Rare Disease Diagnosis
Revvity, Inc., a pioneering force in genomic sequencing technology, has announced the launch of a groundbreaking "sample-to-answer" workflow tailored speci...
March 18, 2024 | News
CStone's Sugemalimab Granted Historic Approval in China for Gastric Cancer Treatment
CStone Pharmaceuticals has achieved a significant milestone with the approval of sugemalimab (Cejemly®) by the National Medical Products Administration...
March 18, 2024 | News
BeiGene's TEVIMBRA Wins FDA Nod for Advanced Esophageal Cancer Post-Chemotherapy
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has app...
March 15, 2024 | News
Almirall and Eloxx Pharmaceuticals Forge Exclusive Global License Agreement for Rare Disease Treatment ZKN-013
Almirall, S.A. (BME:ALM), a global biopharmaceutical company, and Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a clinical-stage biopharmaceutical innovator, ha...
March 14, 2024 | News
TiumBio Advances TU2218 in Phase 2a Trial with Pembrolizumab for Three Cancer Types
TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab TU2218 demonstrated a favorable safety and a synerget...
March 12, 2024 | News
Eisai Boosts Support for Alzheimer's Diagnosis with $15 Million Investment in C2N Diagnostics
Eisai Co., Ltd. announced a significant step forward in the fight against Alzheimer's disease (AD) today, with its U.S. subsidiary Eisai Inc. committing up...
March 07, 2024 | News
BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX
Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...
March 07, 2024 | News
Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy
Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...
March 06, 2024 | News
Innovent Biologics and AnHeart Therapeutics Secure Second NDA Acceptance for Groundbreaking Lung Cancer Treatment in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
March 06, 2024 | News
Telix Pharmaceuticals Acquires ARTMS Inc. to Revolutionize Radioisotope Production
Telix Pharmaceuticals announced its acquisition of radioisotope production technology firm ARTMS Inc. ("ARTMS"), including its advanced cyclotron-based iso...
March 05, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
